Drug Type Autologous CAR-T |
Synonyms Autologous EpCAM specific CAR-T cell injection (Immunofoco Biotech), IMC 001(Immunofoco Biotech), IMC001 + [1] |
Target |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors) |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Colorectal Adenocarcinoma | Phase 1 | CN | 30 Sep 2021 | |
Advanced gastric carcinoma | Phase 1 | CN | 30 Sep 2021 | |
Advanced Hepatocellular Carcinoma | Phase 1 | CN | 30 Sep 2021 | |
Advanced Pancreatic Adenocarcinoma | Phase 1 | CN | 30 Sep 2021 | |
Digestive System Neoplasms | IND Approval | US | 23 Feb 2024 |
Early Phase 1 | 7 | IMC001 3×10ˆ5 cells/kg | ivfbpcdrek(ycnjrqfpzm) = eqaoqfwuga vvpodpjiys (egtwkdehqc ) View more | Positive | 10 Sep 2022 |